Hennekam-Beemer syndrome
diseaseOn this page
Also known as Hennekam Beemer syndromemastocytosis cutaneous with short stature conductive hearing loss and microtiamastocytosis-short stature-hearing loss syndromeskin mastocytosis hearing loss microcephaly mild dysmorphic features and severe intellectual disabilityskin mastocytosis hearing loss microcephaly mild dysmorphic features and severe mental retardation
Summary
Hennekam-Beemer syndrome (MONDO:0009569) is a disease. A subtype of multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 52
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 3 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
52 HPO clinical features (Orphanet curated; top 50 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000179 | Thick lower lip vermilion | Very frequent (80-99%) |
| HP:0000218 | High palate | Very frequent (80-99%) |
| HP:0000325 | Triangular face | Very frequent (80-99%) |
| HP:0000648 | Optic atrophy | Very frequent (80-99%) |
| HP:0000989 | Pruritus | Very frequent (80-99%) |
| HP:0001000 | Abnormality of skin pigmentation | Very frequent (80-99%) |
| HP:0001252 | Hypotonia | Very frequent (80-99%) |
| HP:0001284 | Areflexia | Very frequent (80-99%) |
| HP:0001508 | Failure to thrive | Very frequent (80-99%) |
| HP:0002119 | Ventriculomegaly | Very frequent (80-99%) |
| HP:0004322 | Short stature | Very frequent (80-99%) |
| HP:0008551 | Microtia | Very frequent (80-99%) |
| HP:0200034 | Papule | Very frequent (80-99%) |
| HP:0000252 | Microcephaly | Very frequent (80-99%) |
| HP:0000270 | Delayed cranial suture closure | Very frequent (80-99%) |
| HP:0000347 | Micrognathia | Very frequent (80-99%) |
| HP:0000365 | Hearing impairment | Very frequent (80-99%) |
| HP:0000405 | Conductive hearing impairment | Very frequent (80-99%) |
| HP:0000520 | Proptosis | Very frequent (80-99%) |
| HP:0000582 | Upslanted palpebral fissure | Very frequent (80-99%) |
| HP:0001025 | Urticaria | Very frequent (80-99%) |
| HP:0001250 | Seizure | Very frequent (80-99%) |
| HP:0001482 | Subcutaneous nodule | Very frequent (80-99%) |
| HP:0002027 | Abdominal pain | Very frequent (80-99%) |
| HP:0004209 | Clinodactyly of the 5th finger | Very frequent (80-99%) |
| HP:0007400 | Irregular hyperpigmentation | Very frequent (80-99%) |
| HP:0007440 | Generalized hyperpigmentation | Very frequent (80-99%) |
| HP:0010783 | Erythema | Very frequent (80-99%) |
| HP:0012733 | Macule | Very frequent (80-99%) |
| HP:0100490 | Camptodactyly of finger | Very frequent (80-99%) |
| HP:0100495 | Mastocytosis | Very frequent (80-99%) |
| HP:0001249 | Intellectual disability | Occasional (5-29%) |
| HP:0002090 | Pneumonia | Occasional (5-29%) |
| HP:0002093 | Respiratory insufficiency | Occasional (5-29%) |
| HP:0002615 | Hypotension | Occasional (5-29%) |
| HP:0002650 | Scoliosis | Occasional (5-29%) |
| HP:0011344 | Severe global developmental delay | Occasional (5-29%) |
| HP:0012378 | Fatigue | Occasional (5-29%) |
| HP:0100559 | Lower limb asymmetry | Occasional (5-29%) |
| HP:0000336 | Prominent supraorbital ridges | Occasional (5-29%) |
| HP:0000431 | Wide nasal bridge | Occasional (5-29%) |
| HP:0000445 | Wide nose | Occasional (5-29%) |
| HP:0000737 | Irritability | Occasional (5-29%) |
| HP:0000924 | Abnormality of the skeletal system | Occasional (5-29%) |
| HP:0001072 | Thickened skin | Occasional (5-29%) |
| HP:0002013 | Vomiting | Occasional (5-29%) |
| HP:0003189 | Long nose | Occasional (5-29%) |
| HP:0011675 | Arrhythmia | Occasional (5-29%) |
| HP:0100326 | Immunologic hypersensitivity | Occasional (5-29%) |
| HP:0100585 | Telangiectasia of the skin | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Hennekam-Beemer syndrome |
| Mondo ID | MONDO:0009569 |
| MeSH | C536033 |
| OMIM | 248910 |
| Orphanet | 2135 |
| ICD-10-CM | Q82.2 |
| SNOMED CT | 722453009 |
| UMLS | C3151493 |
| MedGen | 462843 |
| GARD | 0003409 |
| Is cancer (heuristic) | no |
Also known as: Hennekam Beemer syndrome · mastocytosis cutaneous with short stature conductive hearing loss and microtia · mastocytosis-short stature-hearing loss syndrome · skin mastocytosis hearing loss microcephaly mild dysmorphic features and severe intellectual disability · skin mastocytosis hearing loss microcephaly mild dysmorphic features and severe mental retardation
Disease family
Classification path: disease › human disease › disease by developmental or physiological process › disorder of development or morphogenesis › developmental defect during embryogenesis › multiple congenital anomalies/dysmorphic syndrome › multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome › Hennekam-Beemer syndrome
Related subtypes (68): acromegaloid facial appearance syndrome, Hypoglossia-hypodactyly syndrome, Brachymorphism-onychodysplasia-dysphalangism syndrome, campomelic dysplasia, cerebrocostomandibular syndrome, autosomal dominant popliteal pterygium syndrome, Pallister-Hall syndrome, autosomal dominant primary microcephaly, microgastria-limb reduction defect syndrome, Mobius syndrome, oculodentodigital dysplasia, Char syndrome, Prader-Willi syndrome, Silver-Russell syndrome, ulnar-mammary syndrome, short stature-wormian bones-dextrocardia syndrome, ablepharon macrostomia syndrome, Goodman syndrome, anophthalmia/microphthalmia-esophageal atresia syndrome, microphthalmia with limb anomalies, Antley-Bixler syndrome, campomelia, Cumming type, CHARGE syndrome, Toriello-Carey syndrome, Donnai-Barrow syndrome, lethal faciocardiomelic dysplasia, hypertrichotic osteochondrodysplasia Cantu type, hypomandibular faciocranial dysostosis, isotretinoin-like syndrome, split hand-foot malformation 3, oculotrichoanal syndrome, Mietens syndrome, Schinzel-Giedion syndrome, SHORT syndrome, moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome, occipital horn syndrome, hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome, Potocki-Shaffer syndrome, Marshall-Smith syndrome, PHACE syndrome, Noonan syndrome-like disorder with loose anagen hair, branchiogenic deafness syndrome, combined immunodeficiency with faciooculoskeletal anomalies, chromosome 1p32-p31 deletion syndrome, Malan overgrowth syndrome, dysmorphism-conductive hearing loss-heart defect syndrome, TELO2-related intellectual disability-neurodevelopmental disorder, short stature-heart defect-craniofacial anomalies syndrome, arachnodactyly-intellectual disability-dysmorphism syndrome, polyvalvular heart disease syndrome, Kallmann syndrome-heart disease syndrome, Meier-Gorlin syndrome, symptomatic form of Coffin-Lowry syndrome in female carriers, Prader-Willi-like syndrome, contractures-developmental delay-Pierre Robin syndrome, 22q11.2 deletion syndrome, Noonan syndrome, Carpenter syndrome, Bosley-Salih-Alorainy syndrome, Sotos syndrome, Robinow syndrome, King-Denborough syndrome, Weiss-Kruszka syndrome, retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome, omphalocele-diaphragmatic hernia-cardiovascular anomalies-radial ray defect syndrome, 4q25 proximal deletion syndrome, restrictive dermopathy 1, mosaic SMO syndrome
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.